European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents
Open Access
- 15 March 2026
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (S4) , e70194
Abstract
Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence‐informed and consensus‐driven recommendations. Using a literature review and GRADE methodology, we address clinical evaluation, imaging pathology, genetics, surgical and systemic therapies, and long‐term surveillance. Surgical resection is the cornerstone in localized disease. Systemic treatments are largely adapted from adult data, including somatostatin analogues, radiopharmaceutical therapy, and targeted agents. Multidisciplinary care, genetic counseling, and lifelong follow‐up are essential to optimize outcomes.Keywords
Funding Information
- Deutsche Kinderkrebsstiftung
This publication has 95 references indexed in Scilit:
- Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJAMA Oncology, 2024
- Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020Pediatric Blood & Cancer, 2024
- Childhood pancreatic neuroendocrine neoplasms: A national experiencePediatric Blood & Cancer, 2024
- Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive SystemJAMA Oncology, 2022
- Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut‐like profileThe Journal of Pathology, 2022
- Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in childrenPediatric Blood & Cancer, 2021
- Extra‐appendicular neuroendocrine tumors: A report from the TREP project (2000‐2020)Pediatric Blood & Cancer, 2021
- Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 studyCancer, 2020
- Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsJAMA Oncology, 2018
- Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: Nine standard SEER registries, 1975–2006Pediatric Blood & Cancer, 2010